“The team at BMP has been a long-time investor and supporter of our company. Dana, Rob & Marty are thoughtful, supportive and well connected within the biotechnology and medtech community – their expertise, and the benefits of both operator and investor perspectives have been invaluable as we’ve grown our company. They have been exceptional investors and partners for our organization and are truly vested in helping organizations develop products that meet unmet therapeutic needs.”

Adam Gridley, President and Chief Executive Officer Histogenics
Adam Gridley President and Chief Executive Officer Histogenics